Alterity Therapeutics Ltd. (ATHE) stock plunged during pre-market trading. Here’s the recent update
Alterity Therapeutics Ltd. (NASDAQ: ATHE) stock gained by 64.62% at last close whereas the ATHE stock-price declines by 9.35% in the pre-market trading session. Alterity is working on first-in-class neurodegenerative disease treatments. ATH434, their main medication candidate, has shown effectiveness in many animal models of Parkinson’s disease and is currently being tested in human studies. […]
Evercore ISI Group downgrades Athene Holding [ATH] to In-Line
Evercore ISI Group took its Athene Holding [ATH] rating to the equivalent of In-Line from Outperform, in a research note dated 2021-01-08. Other analysts also revised their coverage, with RBC Capital Mkts’s analysts downgrading the shares from “an Outperform” rating to “a Sector perform” rating in a research note to investors issued in mid March. […]
